Research article

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients

Hassan Argani^1,2 , Alireza Noorazarian³ , Mohammad Rahbaninobar^2,4 , Mohammad Noori⁴ and Hamid T Khosroshahi¹

¹  Nephrology Division of Emam Hospital, Tabriz university of medical sciences, Tabriz, Iran

²  Drug Applied Research Center, Tabriz university of medical sciences, Tabriz, Iran

³  Biochemistry Laboratory, Emam Hospital, Tabriz university of medical sciences, Tabriz, Iran

⁴  Biochemistry Division of Medical Faculty, Tabriz university of medical sciences, Tabriz, Iran

author email corresponding author email

BMC Nephrology 2004, 5:11doi:10.1186/1471-2369-5-11

Published:	8 September 2004

Abstract

Background

Impaired glucose tolerance is a risk factor for atherosclerosis in hemodialysis patients and renal transplant recipients.

Methods

To check the relationship of impaired glucose tolerance with the other atherosclerotic risk factors, fasting blood sugar and the standard two hour glucose tolerance test, serum tryglyceride, serum cholesterol, cyclosporine through level (in renal tranpslant recipients) and hemoglobin A1C were measured in 55 stable renal transplant recipients, 55 hemodialysis patients and 55 healthy controls with similar demographic characteristics. Patients with diabetes mellitus and propranolol consumers were excluded. The mean age and female to male ratio were 39 +/- 7 years and 23/22, respectively.

Results

Four of the renal transplant recipients and twelve of the hemodialysis patients had impaired glucose tolerance. Significant linear correlation was observed with body mass index and IGT only in hemodialysis patients (r = 0.4, p = 0.05). Glucose tolerance also had a significant correlation with triglyceride levels (217.2 +/- 55 mg/dl in hemodialysis patients vs. 214.3 +/- 13 mg/dl in renal transplant recipients and 100.2 +/- 18 mg/dl in control groups, p = 0.001). The glucose tolerance had significant relationship with higher serum cholesterol levels only in the renal transplant recipients (269.7 +/- 54 in renal transplant recipients vs. 199.2 +/- 36.6 mg/dl in hemodialysis and 190.5 +/- 34 mg/dl in control groups, p = 0.0001). In the renal transplant recipients, a linear correlation was observed with glucose tolerance and both the serum cyclosporine level (r = 0.9, p = 0.001) and the hemoglobin A1C concentration (6.2 +/- 0.9 g/dl). The later correlation was also observed in the hemodialysis patients (6.4 +/- 0.7 g/dl; r = 67, p = 0.001).

Conclusions

We conclude that although fasting blood sugar is normal in non-diabetic renal transplant and hemodialysis patients, impaired glucose tolerance could be associated with the other atherosclerotic risk factors.